John F. Ginascol net worth and biography

John Ginascol Biography and Net Worth

John Ginascol is Abbott's Executive Vice President, Core Diagnostics. He was appointed to this role in June 2019. Previously, John served as Vice President, Supply Chain for the company's Nutrition business.

In his close to 40-year career in health care, John has amassed a breadth of experience that covers pharmaceuticals, hospital products, medical devices, and nutrition products. In his current role, John is leading a business that is transforming how diagnostic results are delivered – and ultimately how they affect patient care.

Outside of Abbott, John serves on the Board of Directors of the Lake Forest Graduate School of Management, and on the Chicago’s historical Washington Square Park Advisory Committee.

John earned a bachelor of science degree in Chemistry from the University of Texas, Austin, and a Master's in Business (M.B.A.) from the Lake Forest Graduate School of Management.

What is John F. Ginascol's net worth?

The estimated net worth of John F. Ginascol is at least $12.51 million as of December 13th, 2022. Mr. Ginascol owns 111,912 shares of Abbott Laboratories stock worth more than $12,510,642 as of February 5th. This net worth approximation does not reflect any other assets that Mr. Ginascol may own. Learn More about John F. Ginascol's net worth.

What is John F. Ginascol's salary?

As the EVP of Abbott Laboratories, Mr. Ginascol earned a total compensation package of $6,767,029.00 in 2020. Mr. Ginascol earned a salary of $708,269.00, stock awards of $1,653,678.00, options awards of $1,653,987.00, non-equity compensation of $857,300.00, and other compensation of $112,729.00. Learn More on John F. Ginascol's salary.

How do I contact John F. Ginascol?

The corporate mailing address for Mr. Ginascol and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. Abbott Laboratories can also be reached via phone at (224) 667-6100. Learn More on John F. Ginascol's contact information.

Has John F. Ginascol been buying or selling shares of Abbott Laboratories?

John F. Ginascol has not been actively trading shares of Abbott Laboratories during the last quarter. Most recently, John F. Ginascol sold 11,000 shares of the business's stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $112.32, for a transaction totalling $1,235,520.00. Following the completion of the sale, the executive vice president now directly owns 111,912 shares of the company's stock, valued at $12,569,955.84. Learn More on John F. Ginascol's trading history.

Who are Abbott Laboratories' active insiders?

Abbott Laboratories' insider roster includes Hubert Allen (Insider), Roxanne Austin (Director), Roger Bird (SVP), Brian Blaser (Insider), Philip Boudreau (VP), Sharon Bracken (Insider), John Capek (EVP), Jaime Contreras (SVP), Michael Dale (SVP), Lisa Earnhardt (EVP), Robert Ford (Chairman), Robert Ford (CEO), Robert Funck (CFO), Stephen Fussell (EVP), John Ginascol (EVP), Sammy Karam (SVP), Michelle Kumbier (Director), Andrew Lane (EVP), Joseph Manning (SVP), Nancy Mckinstry (Director), Mary Moreland (EVP), Louis Morrone (SVP), Phebe Novakovic (Director), Michael Pederson (SVP), Daniel Salvadori (EVP), Christopher Scoggins (SVP), Daniel Starks (Director), Julie Tyler (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), Miles White (Chairman), Randel Woodgrift (SVP), and Brian Yoor (CFO). Learn More on Abbott Laboratories' active insiders.

Are insiders buying or selling shares of Abbott Laboratories?

During the last year, insiders at the healthcare product maker sold shares 15 times. They sold a total of 347,684 shares worth more than $37,184,729.83. The most recent insider tranaction occured on December, 13th when EVP John F Ginascol sold 11,000 shares worth more than $1,235,520.00. Insiders at Abbott Laboratories own 0.5% of the company. Learn More about insider trades at Abbott Laboratories.

Information on this page was last updated on 12/13/2022.

John F. Ginascol Insider Trading History at Abbott Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2022Sell11,000$112.32$1,235,520.00111,912View SEC Filing Icon  
4/21/2020Sell63,200$96.00$6,067,200.00129,645View SEC Filing Icon  
See Full Table

John F. Ginascol Buying and Selling Activity at Abbott Laboratories

This chart shows John F Ginascol's buying and selling at Abbott Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abbott Laboratories Company Overview

Abbott Laboratories logo
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.
Read More

Today's Range

Now: $111.79
Low: $110.66
High: $112.33

50 Day Range

MA: $109.76
Low: $103.86
High: $114.01

2 Week Range

Now: $111.79
Low: $93.25
High: $130.79

Volume

3,754,480 shs

Average Volume

4,640,867 shs

Market Capitalization

$194.91 billion

P/E Ratio

28.59

Dividend Yield

1.82%

Beta

0.66